Successful ventricular leadless pacemaker retrieval after postprocedural dislodgement into the coronary sinus

Leadless pacemakers (LPM) are an available pacing option for patients with bradycardia. These pacemakers are capsule-like devices that are completely intracardiac, positioned in the right ventricle, and typically placed at the interventricular septum. This technique has emerged as an alternative to transvenous pacemakers (TPMs) to eliminate the complications associated with leads and subcutaneous pockets. Until recently, LPM usage was restricted by its indications area (single-chamber ventricular only) but a new dual chamber leadless pacemaker has emerged recently to allow atrio-ventricular synchronous pacing and is FDA approved since September 20231.